CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
416,598,522
Total 13F shares
135,304,614
Share change
-10,988,558
Total reported value
$413,984,387
Put/Call ratio
46%
Price per share
$3.06
Number of holders
198
Value change
-$32,285,814
Number of buys
87
Number of sells
87

Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2025

As of 30 Sep 2025 CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) had 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 135,304,614 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, PNC Financial Services Group, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, NORTHERN TRUST CORP, Divisadero Street Capital Management, LP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 198 institutional shareholders of the security as of 30 Sep 2025.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.